17.06.2020
Issuance of a 3rd tranche of €1.5 million of notes convertible into new shares
DEINOVE immediately strengthens its cash position by €1.5 million DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that...
Press releases
04.05.2020
Alexis RIDEAU appointed Deputy Chief Executive Officer of DEINOVE with the ambition to strengthen the Company's strategy for innovation and partnerships
• Alexis RIDEAU has recognized experience in the development, negotiation and implementation of strategic partnerships in the life sciences...
29.04.2020
2019 Annual results: A year of important milestones in both Antibiotics and Cosmetics activities
Significant achievements in antibiotic programs: Initiation of the Phase II trial testing DNV3837 as first-line treatment for severe C...
23.04.2020
Official launch of Luminity®, DEINOVE's new cosmetic active ingredient for a radiant complexion
Luminity® is a concentrate of neurosporene, an extremely rare carotenoid that contributes to skin vitality and a beautiful complexion...
03.04.2020
Issuance of a 2nd tranch of €1 million of notes convertible into new shares
DEINOVE immediately strengthens its cash position by €1 million DEINOVE (Euronext Growth Paris: ALDEI), a French biotech company that uses...
01.04.2020
DEINOVE obtains from Société Générale Factoring the pre-funding of its 2019 R&D Tax Credit receivable amounting to EUR 2.1 million
For the second year in a row, DEINOVE has called on Société Générale Factoring (SGF) to pre-finance its R&D Tax Credit receivable...
30.03.2020
In a climate of economic and industrial uncertainty, the collaboration agreement between Sharon Laboratories and Deinove will not be signed
The current health, economic and financial crisis creates too much uncertainty to enter into a long-term full partnership around a complete...
24.03.2020
DEINOVE updates its financial calendar
The 2019 financial results are postponed to April 29, 2020. At this stage, the other dates remain unchanged. DEINOVE (Euronext Growth Paris...
18.03.2020
Commercial launch of BIOME Oléoactif®, new cosmetic active co-developed by Deinove and Hallstar France
BIOME Oléoactif® is an exclusive active ingredient that regulates skin microbiota and reinforces skin barrier function, thanks to a unique...
11.03.2020
DEINOVE passes the 2nd milestone of the AGIR program and receives €1.5m from Bpifrance
The AGIR program, supported by the French Investments for the Future program, aims to accelerate new antibiotics discovery to tackle the...